Friday, January 30, 2026

HK inno.N’s New Drug K-CAB Applies for U.S. FDA Approval: How Innovative Is the P-CAB Therapy?

HK inno.N's K-Cap for GERD has entered the U.S. approval process, showing superior results in clinical trials over existing treatments.

Unstoppable Threat: North Korea Unleashes Precision Weapons Designed To Break US Missile Defense

North Korea's military parade marked the Workers' Party's 80th anniversary, showcasing new precision strike weapons and significant participation.

2026 U.S. Defense Strategy: How South Korea Takes the Lead in Countering North Korea

The Pentagon's new National Defense Strategy shifts North Korea deterrence to South Korea, emphasizing self-defense and alliance strength.

How EverEx’s AI Solutions Are Transforming Musculoskeletal Care in the U.S. Market

HealthHow EverEx's AI Solutions Are Transforming Musculoskeletal Care in the U.S. Market
Yoon Chan, CEO of EverEX, whom I recently met in San Francisco 2026.1.14 / News1
Yoon Chan, CEO of EverEX, whom I recently met in San Francisco 2026.1.14 / News1

EverEx is making waves in the U.S. remote therapy monitoring market, an emerging blue ocean opportunity. The company aims to secure a leadership position with its proprietary artificial intelligence (AI) posture estimation technology and evidence-based rehabilitation exercise curriculum.

This insight comes from Yoon Chan, Chief Executive Officer (CEO) of EverEx, a digital healthcare firm specializing in musculoskeletal issues. Since founding EverEx in August 2019, Yoon has set his sights on expanding the company’s remote rehabilitation monitoring solution, EverEx Rehab, into the U.S. market and elevating the business to new heights.

Industry sources report that Yoon, a Seoul National University College of Medicine graduate and orthopedic specialist, launched EverEx after a decade in the medical field. His goal: to address the challenges faced by patients and doctors dealing with musculoskeletal disorders through digital therapeutic solutions.

According to the Health Insurance Statistical Yearbook, four of the ten most common diseases among seniors 65 and older are musculoskeletal-related. As South Korea transitions into an ultra-aging society, the market for treating these conditions continues to expand. Moreover, many workplace injuries involve musculoskeletal disorders, presenting an opportunity that Yoon is keen to address.

In a recent interview with News1 in San Francisco, Yoon noted that while social interest in musculoskeletal disorders is growing, it lacks effective preventive solutions. Many of these issues stem from repetitive labor in industrial settings, making it crucial for companies to implement preventive measures. Its solution can be highly effective in such scenarios.

EverEx has developed and commercialized four solutions under its musculoskeletal rehabilitation treatment brand, MORA: MORA Care, MORA Vu, MORACure, and MORA Ex.

MORA offers approximately 3,000 exercise movements and over 200 exercise programs targeting ten body areas, including the neck, back, knees, and shoulders. The company’s proprietary AI posture estimation model, Griffin, is a key asset. It can extract 24 joint points using a smartphone camera to estimate posture in real-time, enabling precise movement analysis and facilitating rehabilitation therapy from any location.

Yoon explained that traditionally, rehabilitation patients receive treatment at hospitals and continue their therapy at home. However, medical professionals often lack visibility into patients’ at-home progress, which presents limitations. Its solution provides objective measurements of how rehabilitation is conducted and the extent of improvement achieved.

CEO Yoon Chan is presenting at a recent global investor relations event held in San Francisco, U.S. / Provided by Korea Biotechnology Industry Organization
CEO Yoon Chan is presenting at a recent global investor relations event held in San Francisco, U.S. / Provided by Korea Biotechnology Industry Organization

It will expand the U.S. sales and revolutionize the rehabilitation treatment paradigm.

EverEx has strategically targeted the U.S. market, where a significant shortage of physical therapists often results in long wait times for treatment. This underscores the strong demand for remote therapy solutions. EverEx Rehab has already initiated its U.S. expansion by securing a solution supply agreement with Xenco Medical, a surgical medical device company, in 2024.

Yoon stated that despite its Korean origins, it has received positive feedback from U.S. medical professionals. It is committed to responding swiftly to market demands and building trust through necessary adjustments.

EverEx recently clinched an innovation award at the Consumer Electronics Shows (CES) 2026 in Las Vegas. The company then participated in the Global IR event organized by the Korea Bio Association in San Francisco, successfully capturing the interest of foreign investors.

While Yoon acknowledges the demands of running a global company are overwhelming, he remains energized by the positive feedback and continues to engage actively without showing signs of fatigue.

He emphasized its goal is to create a service where every patient can easily access personalized rehabilitation treatment. In terms of revenue, it is aiming for a fivefold increase in sales this year compared to last. It is committed to transforming the rehabilitation treatment paradigm, enabling anyone to receive customized rehabilitation services without time or space constraints.

Check Out Our Content

Check Out Other Tags:

Most Popular Articles